This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA. Oral CXCR4 antagonist Xolremdi ...
Can You Chip In? We’re celebrating our 1 trillionth archived web page. If you find our library useful, learn how you can help us fundraise! Can You Chip In? We’re celebrating our 1 trillionth archived ...